BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 15366479)

  • 1. [Selective phosphodiesterase 4 inhibition. Controlling inflammation--also in patients with COPD].
    MMW Fortschr Med; 2004 Apr; 146(18):59. PubMed ID: 15366479
    [No Abstract]   [Full Text] [Related]  

  • 2. [Phosphosdiesterase 4 inhibitors in the treatment of pulmonary diseases].
    Xia XD; Dai YR; Xu ZJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jan; 27(1):57-9. PubMed ID: 14989829
    [No Abstract]   [Full Text] [Related]  

  • 3. The potential role of roflumilast: the new phosphodiesterase-4 inhibitor.
    Karish SB; Gagnon JM
    Ann Pharmacother; 2006 Jun; 40(6):1096-104. PubMed ID: 16735669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roflumilast for the treatment of chronic obstructive pulmonary disease.
    Antoniu SA
    Curr Opin Investig Drugs; 2006 May; 7(5):412-7. PubMed ID: 16729716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K
    Eur J Pharmacol; 2006 Mar; 533(1-3):110-7. PubMed ID: 16458289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selective phosphodiesterase-4 (PDE-4) inhibitors in COPD].
    Tatlicioğlu T
    Tuberk Toraks; 2008; 56(4):472-84. PubMed ID: 19123088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AWD-12-281 (inhaled) (elbion/GlaxoSmithKline).
    Gutke HJ; Guse JH; Khobzaoui M; Renukappa-Gutke T; Burnet M
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1149-58. PubMed ID: 16312137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions.
    van Schalkwyk E; Strydom K; Williams Z; Venter L; Leichtl S; Schmid-Wirlitsch C; Bredenbröker D; Bardin PG
    J Allergy Clin Immunol; 2005 Aug; 116(2):292-8. PubMed ID: 16083782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PDE4 inhibitors as new anti-inflammatory drugs: effects on cell trafficking and cell adhesion molecules expression.
    Sanz MJ; Cortijo J; Morcillo EJ
    Pharmacol Ther; 2005 Jun; 106(3):269-97. PubMed ID: 15922015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of chronic obstructive pulmonary disease with roflumilast, a new phosphodiesterase 4 inhibitor.
    Gross NJ; Giembycz MA; Rennard SI
    COPD; 2010 Apr; 7(2):141-53. PubMed ID: 20397815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase 4 inhibition with roflumilast: a new approach to pulmonary disease.
    Doggrell SA
    Expert Opin Pharmacother; 2006 Mar; 7(4):485-8. PubMed ID: 16503820
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of inhaled roflumilast on the prevention and resolution of allergen-induced late phase airflow obstruction in Brown Norway rats.
    Chapman RW; House A; Jones H; Richard J; Celly C; Prelusky D; Ting P; Hunter JC; Lamca J; Phillips JE
    Eur J Pharmacol; 2007 Oct; 571(2-3):215-21. PubMed ID: 17610865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Roflumilast: a new approach to therapy of chronic obstructive pulmonary disease].
    Kreutzkamp B
    Med Monatsschr Pharm; 2010 Jul; 33(7):236-43. PubMed ID: 20687460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease.
    Lipworth BJ
    Lancet; 2005 Jan 8-14; 365(9454):167-75. PubMed ID: 15639300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical profile of roflumilast].
    Izquierdo Alonso JL
    Arch Bronconeumol; 2010 Dec; 46 Suppl 10():25-32. PubMed ID: 21316553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Roflumilast: a new perspective in therapy of chronic obstructive lung disease].
    Mihălţan F; Ulmeanu R
    Pneumologia; 2003; 52(3-4):193-5. PubMed ID: 18210733
    [No Abstract]   [Full Text] [Related]  

  • 17. CC-10004 .
    Khobzaoui M; Gutke HJ; Burnet M
    Curr Opin Investig Drugs; 2005 May; 6(5):518-25. PubMed ID: 15912967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Modern therapy of COPD].
    Pariente R; Aubier M
    Bull Acad Natl Med; 2004; 188(1):67-74; discussion 74-5. PubMed ID: 15368926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COPD, inflammation and its modulation by phosphodiesterase 4 inhibitors: time to look beyond the FEV1.
    Celli B
    Chest; 2006 Jan; 129(1):5-6. PubMed ID: 16424403
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of phosphodiesterase 4 in allergic rhinitis.
    Baraniuk JN; Tai CF
    Curr Allergy Asthma Rep; 2002 May; 2(3):191-2. PubMed ID: 11918859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.